Minims Atropinesulfaat 10 Mg/Ml Oogdruppels, Oplossing (Atropine Sulfate)

Atropine sulfate, the active ingredient in Minims Atropinesulfaat 10 Mg/Ml Oogdruppels, Oplossing, is an anticholinergic presented as a 10 mg/mL ophthalmic solution for ocular use. It provides pupil dilation and cycloplegia for diagnostic eye examinations and helps manage anterior uveitis.

GNH USA supplies Minims Atropinesulfaat 10 Mg/Ml Oogdruppels, Oplossing as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Atropine sulfate is used in ophthalmology to achieve controlled dilation and cycloplegia for various diagnostic and therapeutic purposes.

- Mydriasis for diagnostic eye examinations: provides sustained pupil dilation to facilitate fundus evaluation. - Cycloplegia: temporarily paralyzes accommodation to allow accurate refraction measurements. - Anterior uveitis: reduces intra‑ocular inflammation and associated pain.

Common Side Effects: - Blurred vision: temporary loss of visual clarity after instillation. - Photophobia: increased sensitivity to light due to dilated pupils. - Ocular discomfort: mild irritation or burning sensation. - Redness of the eye: conjunctival hyperemia.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma: sudden rise in intra‑ocular pressure. - Severe allergic reaction (anaphylaxis): systemic hypersensitivity. - Persistent mydriasis: prolonged pupil dilation beyond expected duration. - Corneal edema: swelling of the cornea affecting vision.

Before using atropine eye drops, consider the following precautions. - Assess intra‑ocular pressure: patients with narrow‑angle glaucoma may be at risk. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use caution in pediatric patients: systemic absorption can be higher. - Monitor for systemic anticholinergic effects: especially in elderly or those on other anticholinergics. - Store at ambient temperature: keep in original container, protect from light and moisture.

Atropine sulfate may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent mydriatics (e.g., phenylephrine): may cause excessive dilation. - Systemic anticholinergics (e.g., antihistamines): increase overall anticholinergic load. - MAO inhibitors: can potentiate systemic anticholinergic effects.

Moderate Interactions (Monitor Closely): - Topical beta‑blockers for glaucoma: reduced efficacy when combined. - Other cycloplegic agents (e.g., cyclopentolate): additive cycloplegia. - NSAID eye drops: may increase risk of corneal toxicity.